 role new cephamycin manag obstetr gynecolog infect result vitro vivo studi cefmetazol second-gener cephamycin cefmetazol spectrum activ clinic coverag mani enterobacteriacea staphylococci streptococci haemophilu speci pathogen neisseria organ moraxella branhamella catarrhali anaerob bacteria cefmetazol time potent cefoxitin organ spectra activ staphylococci minim inhibitori micrograms/ml methicillin-resist staphylococcu aureu strain suscept combin fosfomycin cephamycin cefmetazol resist beta-lactamas aerob anaerob bacteria incid advers drug reaction low unit japan drug cost-contain potenti